Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 65


Educational interventions for the management of cancer-related fatigue in adults.

Bennett S, Pigott A, Beller EM, Haines T, Meredith P, Delaney C.

Cochrane Database Syst Rev. 2016 Nov 24;11:CD008144. Review.


Notch-Expanded Murine Hematopoietic Stem and Progenitor Cells Mitigate Death From Lethal Radiation and Convey Immune Tolerance in Mismatched Recipients.

Milano F, Merriam F, Nicoud I, Li J, Gooley TA, Heimfeld S, Imren S, Delaney C.

Stem Cells Transl Med. 2016 Sep 13. pii: sctm.2016-0112. [Epub ahead of print]


Cord-Blood Transplantation in Patients with Minimal Residual Disease.

Milano F, Gooley T, Wood B, Woolfrey A, Flowers ME, Doney K, Witherspoon R, Mielcarek M, Deeg JH, Sorror M, Dahlberg A, Sandmaier BM, Salit R, Petersdorf E, Appelbaum FR, Delaney C.

N Engl J Med. 2016 Sep 8;375(10):944-53. doi: 10.1056/NEJMoa1602074.


Chronic graft versus host disease burden and late transplant complications are lower following adult double cord blood versus matched unrelated donor peripheral blood transplantation.

Gutman JA, Ross K, Smith C, Myint H, Lee CK, Salit R, Milano F, Delaney C, Gao D, Pollyea DA.

Bone Marrow Transplant. 2016 Jul 11. doi: 10.1038/bmt.2016.186. [Epub ahead of print]


Infusion of a non-HLA-matched ex-vivo expanded cord blood progenitor cell product after intensive acute myeloid leukaemia chemotherapy: a phase 1 trial.

Delaney C, Milano F, Cicconi L, Othus M, Becker PS, Sandhu V, Nicoud I, Dahlberg A, Bernstein ID, Appelbaum FR, Estey EH.

Lancet Haematol. 2016 Jul;3(7):e330-9. doi: 10.1016/S2352-3026(16)30023-0.


Evaluation of allogeneic transplantation in first or later minimal residual disease - negative remission following adult-inspired therapy for acute lymphoblastic leukemia.

Cassaday RD, Alan Potts D Jr, Stevenson PA, Bar M, Georges GE, Shustov AR, Sorror ML, Wood BL, Delaney C, Doney KC, Storb RF, Sandmaier BM.

Leuk Lymphoma. 2016 Sep;57(9):2109-18. doi: 10.3109/10428194.2016.1160080.


Outcomes of Cord Blood Transplantation as Salvage Therapy after Graft Failure or Relapse after Prior Allogeneic Transplantation.

Salit RB, Milano F, Delaney C.

Biol Blood Marrow Transplant. 2016 Feb;22(2):339-43. doi: 10.1016/j.bbmt.2015.10.013.


Analysis of DNA Methylation by Pyrosequencing.

Delaney C, Garg SK, Yung R.

Methods Mol Biol. 2015;1343:249-64. doi: 10.1007/978-1-4939-2963-4_19.


Cellular engineering and therapy in combination with cord blood allografting in pediatric recipients.

Cairo MS, Tarek N, Lee DA, Delaney C.

Bone Marrow Transplant. 2016 Jan;51(1):27-33. doi: 10.1038/bmt.2015.196. Review.


Lack of EC-SOD worsens alveolar and vascular development in a neonatal mouse model of bleomycin-induced bronchopulmonary dysplasia and pulmonary hypertension.

Delaney C, Wright RH, Tang JR, Woods C, Villegas L, Sherlock L, Savani RC, Abman SH, Nozik-Grayck E.

Pediatr Res. 2015 Dec;78(6):634-40. doi: 10.1038/pr.2015.166.


Human herpesvirus 6B reactivation and delirium are frequent and associated events after cord blood transplantation.

Hill JA, Boeckh M, Leisenring WM, Xie H, Adler AL, Huang ML, Fann JR, Delaney C, Zerr DM.

Bone Marrow Transplant. 2015 Oct;50(10):1348-51. doi: 10.1038/bmt.2015.154.


Pharmacogenomics of EGFR-targeted therapies in non-small cell lung cancer: EGFR and beyond.

Delaney C, Frank S, Huang RS.

Chin J Cancer. 2015 Apr 8;34(4):149-60. doi: 10.1186/s40880-015-0007-9. Review.


Do dietary patterns in older age influence the development of cancer and cardiovascular disease: A longitudinal study of ageing.

Nobbs HM, Yaxley A, Thomas J, Delaney C, Koczwara B, Luszcz M, Miller M.

Clin Nutr. 2016 Apr;35(2):528-35. doi: 10.1016/j.clnu.2015.04.003.


DOT1L inhibits SIRT1-mediated epigenetic silencing to maintain leukemic gene expression in MLL-rearranged leukemia.

Chen CW, Koche RP, Sinha AU, Deshpande AJ, Zhu N, Eng R, Doench JG, Xu H, Chu SH, Qi J, Wang X, Delaney C, Bernt KM, Root DE, Hahn WC, Bradner JE, Armstrong SA.

Nat Med. 2015 Apr;21(4):335-43. doi: 10.1038/nm.3832.


Notch-mediated expansion of cord blood progenitors: maintenance of transcriptional and epigenetic fidelity.

Dahlberg A, Woo S, Delaney C, Boyle P, Gnirke A, Bock C, Bernstein BE, Meissner A, Gottardo R, Bernstein ID.

Leukemia. 2015 Sep;29(9):1948-51. doi: 10.1038/leu.2015.61. No abstract available.


One-unit versus two-unit cord-blood transplantation for hematologic cancers.

Wagner JE Jr, Eapen M, Carter S, Wang Y, Schultz KR, Wall DA, Bunin N, Delaney C, Haut P, Margolis D, Peres E, Verneris MR, Walters M, Horowitz MM, Kurtzberg J; Blood and Marrow Transplant Clinical Trials Network..

N Engl J Med. 2014 Oct 30;371(18):1685-94. doi: 10.1056/NEJMoa1405584.


Treosulfan-based conditioning and hematopoietic cell transplantation for nonmalignant diseases: a prospective multicenter trial.

Burroughs LM, Nemecek ER, Torgerson TR, Storer BE, Talano JA, Domm J, Giller RH, Shimamura A, Delaney C, Skoda-Smith S, Thakar MS, Baker KS, Rawlings DJ, Englund JA, Flowers ME, Deeg HJ, Storb R, Woolfrey AE.

Biol Blood Marrow Transplant. 2014 Dec;20(12):1996-2003. doi: 10.1016/j.bbmt.2014.08.020.


Enhanced generation of cord blood hematopoietic stem and progenitor cells by culture with StemRegenin1 and Delta1(Ext-IgG.).

Dahlberg A, Brashem-Stein C, Delaney C, Bernstein ID.

Leukemia. 2014 Oct;28(10):2097-101. doi: 10.1038/leu.2014.181. No abstract available.


Do the benefits outweigh the side effects of colorectal cancer surveillance? A systematic review.

Augestad KM, Rose J, Crawshaw B, Cooper G, Delaney C.

World J Gastrointest Oncol. 2014 May 15;6(5):104-11. doi: 10.4251/wjgo.v6.i5.104. Review.


Impact of minimal residual disease, detected by flow cytometry, on outcome of myeloablative hematopoietic cell transplantation for acute lymphoblastic leukemia.

Bar M, Wood BL, Radich JP, Doney KC, Woolfrey AE, Delaney C, Appelbaum FR, Gooley TA.

Leuk Res Treatment. 2014;2014:421723. doi: 10.1155/2014/421723.

Items per page

Supplemental Content

Loading ...
Support Center